Englander Institute for Precision Medicine
News & Events

News & Events

Join our frequent seminar series, case conferences, consortium meetings, and more!

2020 Virtual Summer Internship Program

March 26, 2021

Engaging STEM Students in a Virtual World: MCC-EIPM 2020 Virtual Summer Internship Program

 

How Excess Blood Sugar Disrupts Immune System

March 17, 2021

Excess Blood Sugar Disrupts Immune System Proteins and Promotes Atherosclerosis

Excess sugar in the blood, the central feature of diabetes, can react with immune proteins to cause myriad changes in the immune system, including inflammatory changes that promote atherosclerosis, according to a new study from scientists at Weill Cornell Medicine and University of Massachusetts Medical School.

First and Largest Genetic Study in Middle East

February 25, 2021

QATAR GENOME RESEARCH CONSORTIUM REPORTS FIRST AND LARGEST COMPREHENSIVE GENETIC ASSOCIATION STUDY IN MIDDLE EAST

The first and largest genetic association study in the Middle East revealed genetic variations that are specific to the Qatari population, a group of researchers at Qatar Foundation reported Feb. 23 in Nature Communications.

What Does the Future of Work Look Like?

February 23, 2021

Can virtual reality be the future of work? NBC News/Peacock tries to answer that question in episode 5 of their series, “What Does the Nature of Work Look Like?”

In this episode Alex Sigaras, Director of the AI-XR Lab at the Englander Institute for Precision Medicine, explains how he and his colleagues were using mixed reality before the pandemic to unravel the secrets behind a patients’ genetic makeup.

Longevity Genes and Brain Health

February 22, 2021

Studies of humans who live longer than 100 years have shown that many share an unusual version of a gene called Forkhead box protein 03 (FOX03). That discovery led Dr. Jihye Paik, assoc. prof. of pathology and laboratory medicine, and her colleagues, including EIPM Member Lewis C. Cantley, to investigate how this gene contributes to brain health during aging. 

In 2018, Dr.

New Precision Medicine Approach to Lymphoma

February 4, 2021

TUMOR MICROENVIRONMENT SEEN AS A NEW PLAYER IN AGGRESSIVE LYMPHOMAS

The environment surrounding the cancerous cells of a lymphoma tumor has a strong influence on the progression of these blood-cell cancers and their responses to therapies, according to a study by Weill Cornell Medicine investigators. Measuring this molecular and cellular environment, or “microenvironment,” may represent a new type of precision-medicine approach to lymphoma classification and treatment.

Patient-Centered Care

February 2, 2021

Patient-Centered Approach in Treating Thymoma

Life at 40 years old was good for Amara MacPhee. She’d lost about 40 pounds, was eating well, enjoyed spending time outside, and, even with a busy professional life, was able to carve out time for a few dance HIIT (high intensity interval training) classes a week.

“I had a very active lifestyle between work, seeing friends, and family,” Amara says. “At the time [2016], I was in the best shape of my life.”

Then Amara noticed that she was struggling during a fitness class.

Creating a Culture of Mentorship

January 26, 2021

CREATING A CULTURE OF MENTORSHIP

 

The Englander Institute for Precision Medicine (EIPM) is proud of its track record in creating opportunities for students at every level to learn about the promise and potential of precision medicine to create breakthroughs and improve patient outcomes. The EIPM takes mentoring very seriously, recognizing that inspiring the next generation of investigators is critically important.

EIPM Teams Awarded Funding from Starr Consortium

January 15, 2021

New Collaborations Awarded Funding from Starr Cancer Consortium

EIPM 4Q 2020 External Newsletter

January 7, 2021

Dear Friends of the EIPM,

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021